Prevymis (letermovir) - Merck (MSD)
Does early letermovir initiation delay engraftment? (PubMed, Antimicrob Agents Chemother) - Jun 5, 2026 - "Among 314 consecutive allo-HCTR+, engraftment was significantly delayed in allo-HCTR+ in the letermovir period, even after removing potential confounders, and despite improved survival. Similar trends were found after reviewing the literature, and this observation should raise vigilance." 
Journal • Bone Marrow Transplantation • Cytomegalovirus Infection • Hematological Disorders • Infectious Disease • Transplantation
http://www.ncbi.nlm.nih.gov/pubmed/42240381
 
Catia Vieira Gomes; Christian van Delden; Dionysios Neofytos; Laurent Kaiser; Léna Royston; Ming Zou; Stavroula Masouridi-Levrat; Yves Chalandon
 
Jun 5, 2026
 
Prev Next